Anticholesteremic agent

From Citizendium
Jump to navigation Jump to search
This article is developing and not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Anticholesteremic_agent&printable=yes
This editable Main Article is under development and subject to a disclaimer.

In medicine, an anticholesteremic agent is any drug used to lower the serum cholesterol in the treatment of hypercholesterolemia."

Classification

Hydroxymethylglutaryl-coenzyme A reductase inhibitors (Statins)

The U.S. Preventive Services Task Force (USPSTF) estimated that after 5 to 7 years of treatment with statins, the relative risk reduction of coronary heart disease events is decreased by approximately 30%[1][2]. More recently, a meta-analysis reported an almost identical relative risk reduction of 29.2% in low risk patients treated for 4.3 years [3]. A relative risk reduction of 19% in coronary mortality was found in a meta-analysis of patients at all levels of risk.[4]

Statins benefit patients with high fish oil consumption.[5]

Fibrates

Fibrates (fibric acid derivatives)

Bile acid sequestrants

Bile acid sequestrants

Niacin

Uses

For more information, see: Hypercholesterolemia.


References

  1. ↑ Pignone MP, Phillips CJ, Atkins D, Teutsch SM, Mulrow CD, Lohr KN (2001). "Screening and treating adults for lipid disorders". American Journal of Preventive Medicine 20: 77–89. PMID 11306236. [e]
  2. ↑ Screening for Lipid Disorders: Recommendations and Rationale. Retrieved on 2007-10-17.
  3. ↑ Thavendiranathan P, Bagai A, Brookhart M, Choudhry N (2006). "Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials". Arch Intern Med 166: 2307-13. DOI:10.1001/archinte.166.21.2307. PMID 17130382. Research Blogging.
  4. ↑ Baigent C, Keech A, Kearney PM, et al (2005). "Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins". Lancet 366 (9493): 1267-78. DOI:10.1016/S0140-6736(05)67394-1. PMID 16214597. Research Blogging.
  5. ↑ Nakamura H, Arakawa K, Itakura H, et al (September 2006). "Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial". Lancet 368 (9542): 1155–63. DOI:10.1016/S0140-6736(06)69472-5. PMID 17011942. Research Blogging.
Retrieved from "https://citizendium.org/wiki/index.php?title=Anticholesteremic_agent&oldid=580893"